Group 1 - The core viewpoint of the article is that the Shanghai Stock Exchange issued two regulatory warnings to companies Yahui Long and Yingjixin for inaccuracies and incompleteness in disclosing information related to their "brain-computer interface" business [1] Group 2 - The regulatory warnings were issued on January 7, indicating a proactive approach by the exchange to ensure transparency and accuracy in financial disclosures [1] - The companies involved are listed on the Sci-Tech Innovation Board, highlighting the importance of compliance in emerging technology sectors [1] - The specific nature of the inaccuracies and incompleteness in the disclosures has not been detailed, but it raises concerns about corporate governance and investor trust [1]

当前市场对"脑机接口"相关概念高度关注，公司发布相关信息尤其应当注意审慎、准确，避免对投资者 产生误导。公司E互动平台回复内容未能准确反映公司IPA1299芯片产品的推出主体、销售规模、国际 产品路径差异，也未就未来销售情况存在不确定性等情况充分提示风险，信息披露不准确、不完整，风 险提示不充分。 公司上述行为违反了《上海证券交易所科创板股票上市规则》第1.4条，《上海证券交易所科创板上市 公司自律监管指引第1号——规范运作》第8.1条等规定。公司时任董事会秘书吴任超作为公司信息披露 的具体负责人，未能勤勉尽责，对公司上述违规行为负有责任。 上交所科创板公司管理部作出如下监管措施决定：对深圳英集芯科技股份有限公司及时任董事会秘书吴 任超予以监管警示。 1月7日，上交所科创板公司管理部发布关于对深圳英集芯科技股份有限公司及有关责任人予以监管警示 的决定。 经查明，深圳英集芯科技股份有限公司（下称英集芯）于2026年1月6日在上证E互动平台回复投资者提 问时，提到公司已涉足脑机接口芯片领域，推出的IPA1299芯片专用于人体生物电信号的高精度测量， 可适用于脑电信号采集等脑机接口相关场景，已量产出货，性能参数可媲 ...

据国家企业信用信息公示系统，精芯唯尔成立于2023年9月，注册资本117.65万元，英集芯2023年12月 首次入股该公司，目前上市公司持股比例为15%。 就在前一日（1月6日）13时许，英集芯在回复投资者提问时表示，公司通过早期投资布局，已涉足脑机 接口芯片领域。IPA1299芯片已量产出货，性能参数可媲美海外头部芯片产品。公司还将持续投入资 源，深耕脑机接口相关技术。 1月7日，英集芯（SH688209，股价22.48元，市值97.51亿元）发布公告，对公司6日在上证E互动平台回 复投资者"脑机接口"相关问题进行说明。 英集芯表示，公司与参股公司精芯唯尔（常州）电子科技有限公司（以下简称"精芯唯尔"）共同推出的 IPA1299是一款支持8通道低噪声设计，24位同步采样模数转换器芯片（ADC），主要应用于脑电图 （EEG）、心电图（ECG）和肌电图（EMG）。该产品主要特点在于可实现高精度信号采集功能，可 应用于非侵入式脑机接口领域。 英集芯公告显示，该产品用于人体生物电信号的高精度测量，其适用于各种可穿戴式设备应用场景，技 术路线与当前国际上的侵入式脑机接口存在显著技术路径差异。 公司表示，该产品在非侵入 ...

Core Viewpoint - The company, Yingjixin Technology Co., Ltd., has shown significant growth in revenue and profit, driven by its advancements in power management and fast charging protocol chips, particularly in the automotive and consumer electronics sectors [8]. Group 1: Company Performance - As of September 30, 2025, the company achieved a revenue of 1.169 billion yuan, representing a year-on-year growth of 14.16% [8]. - The net profit attributable to the parent company was 114 million yuan, reflecting a year-on-year increase of 28.54% [8]. - The company has distributed a total of 171 million yuan in dividends since its A-share listing, with 155 million yuan distributed over the past three years [9]. Group 2: Product Development and Market Position - The company successfully developed automotive-grade charging chips that meet AEC-Q100 standards, which have been adopted by domestic and international automotive manufacturers and are now in mass production [2]. - Yingjixin's TWS earphone charging case chips provide high integration power solutions, supporting deep customization of MCU software, which reduces design complexity and material costs for customers [2]. - The company has established itself as a major supplier of power management and fast charging protocol chips in the consumer electronics market, leveraging its advantages in mobile power and fast charging adapters [2]. Group 3: Industry Recognition - Yingjixin has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is the highest honor for small and medium-sized enterprises in China, indicating its strong market position and innovation capabilities [3]. Group 4: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders increased to 15,600, a rise of 13.58% from the previous period [8]. - The average trading cost of the stock is 21.74 yuan, with the stock price approaching a resistance level of 22.90 yuan, indicating potential for upward movement if this level is surpassed [6].

Group 1: Interest Rate Adjustments - The three-year fixed deposit product with an interest rate of 2.2% was officially removed on January 5, with all deposit rates decreasing by 20 basis points [1] - Multiple small and medium-sized banks, including Wuding Xingfu Village Bank and Xuwen Rural Commercial Bank, have recently announced adjustments to their deposit rates, indicating a trend of flexible management based on individual bank conditions [1] Group 2: Currency and Asset Trends - The offshore RMB exchange rate against the USD rose again on January 6, remaining above the 7 yuan mark, continuing a trend of appreciation that has lasted nearly nine months [1] - Analysts believe that the strengthening of the RMB is beneficial for foreign capital inflow, improving liquidity and risk appetite in the A-share market, with three asset categories highlighted for investment: aviation, paper manufacturing, and high-growth sectors like computing and electronics [1] Group 3: Company Performance Forecasts - Eleven companies are expected to achieve their highest net profits in the past decade by 2025, with Zijin Mining and Luxshare Precision leading with lower limits of 51 billion yuan and over 16.5 billion yuan, respectively [2] - The performance of the non-ferrous metals sector is expected to be strong due to supply constraints and structural demand growth, with companies like China Uranium Industry also anticipated to reach peak profits [2] Group 4: Lithium Carbonate Price Surge - Lithium carbonate prices have surged significantly, with a 7.74% increase on January 5 and an 8.99% increase on January 6, reaching 137,900 yuan per ton, driven by tightening supply expectations and rising demand [3] - The price increase is linked to uncertainties in lithium supply and growing demand for energy storage, with market analysts suggesting limited downside potential for lithium prices [3] Group 5: Corporate Developments - Yunnan Metallurgical Group is publicly offering a 3.18% stake in Cheng Tai Insurance for a base price of 184 million yuan, marking the third attempt to transfer this stake [6] - Four companies, including Suzhou Shangshun Technology, have initiated listing counseling as of January 6, indicating ongoing activity in the capital markets [6] Group 6: Stock Market Movements - The three major U.S. stock indices closed higher, with the Dow Jones up 0.99%, driven by AI-related demand, while the S&P 500 and Dow reached historical highs [17] - Commodity prices, particularly metals, have seen significant increases, with copper and nickel reaching record highs, reflecting strong market conditions [17]

截至公告披露日，该产品在非侵入式脑机接口领域尚处于市场培育期，尚未实现规模化销售，暂未对公 司业绩产生重大影响，未来销售情况存在不确定性。 格隆汇1月7日丨英集芯(688209.SH)公布，公司于2026 年1 月6 日在上证 E 互动平台就投资者"脑机接 口"相关问题作出回复，为保障广大投资者的合法权益，公司就相关业务情况补充说明，并进行风险事 项提示如下，敬请广大投资者审慎决策，注意投资风险。 公司与参股公司精芯唯尔(常州)电子科技有限公司(以下简称"精芯唯尔")共同推出的 IPA1299 是一款支 持 8 通道低噪声设计，24 位同步采样模数转换器芯片(ADC)，主要应用于脑电图(EEG)、心电图(ECG) 和肌电图(EMG)，该产品主要特点在于可实现高精度信号采集功能，可应用于非侵入式脑机接口领域。 该产品用于人体生物电信号的高精度测量，其适用于各种可穿戴式设备应用场景，技术路线与当前国际 上的侵入式脑机接口存在显著技术路径差异。 ...

Core Viewpoint - The brain-computer interface (BCI) concept continues to gain traction, with multiple listed companies responding positively to the trend, leading to significant stock price increases in the sector [2][3]. Group 1: Stock Performance - On January 6, several companies in the BCI sector, including Weisi Medical, Sanbo Brain Science, and Aipeng Medical, saw their stocks hit the daily limit, with many achieving consecutive gains [3]. - Weisi Medical's stock rose by 20.01% to 69.70, while Sanbo Brain Science also increased by 20.01% to 84.94, indicating strong market interest [4][5]. Group 2: Company Developments - Weisi Medical is expanding its technology layout in the neuro-rehabilitation field from a single device to a comprehensive solution covering diagnosis, treatment, and rehabilitation [4]. - Sanbo Brain Science has established a BCI laboratory and is developing a product system that includes various applications in clinical diagnosis and neuro-rehabilitation [4]. - Aipeng Medical emphasizes the role of BCI as a bridge between the brain and external devices, highlighting its potential applications [5]. Group 3: Market Trends and Projections - The rehabilitation medical device sector is a key focus area, with companies like Xiangyu Medical aiming to enter over 1,000 top-tier hospitals in China, indicating a robust commercialization strategy [11]. - The global BCI market is projected to reach approximately $12.4 billion by 2034, with a CAGR of 17% from 2025 to 2034, reflecting significant growth potential [17]. Group 4: Collaborations and Innovations - Companies are exploring collaborations to integrate BCI technology with robotics, as seen in the partnership between Yijia and Maillande to develop brain-controlled robots [13]. - Blue Si Technology has become a strategic investor in Qiangnao Technology, indicating strong interest in the BCI hardware sector [14]. - Qiangnao Technology recently completed a financing round of approximately 2 billion, making it the second-largest financing in the BCI field after Neuralink [15].

公司与参股公司精芯唯尔(常州)电子科技有限公司(以下简称"精芯唯尔")共同推出的IPA1299是一款支持 8通道低噪声设计，24位同步采样模数转换器芯片(ADC)，主要应用于脑电图(EEG)、心电图(ECG)和肌 电图(EMG)，该产品主要特点在于可实现高精度信号采集功能，可应用于非侵入式脑机接口领域。该产 品用于人体生物电信号的高精度测量，其适用于各种可穿戴式设备应用场景，技术路线与当前国际上的 侵入式脑机接口存在显著技术路径差异。 英集芯(688209.SH)发布公告，公司于2026年1月6日在上证E互动平台就投资者"脑机接口"相关问题作出 回复，为保障广大投资者的合法权益，公司就相关业务情况补充说明，并进行风险事项提示如下： 截至本公告披露日，该产品在非侵入式脑机接口领域尚处于市场培育期，尚未实现规模化销售，暂未对 公司业绩产生重大影响，未来销售情况存在不确定性。 ...

公司与参股公司精芯唯尔(常州)电子科技有限公司(以下简称"精芯唯尔")共同推出的IPA1299是一款支持 8通道低噪声设计，24位同步采样模数转换器芯片(ADC)，主要应用于脑电图(EEG)、心电图(ECG)和肌 电图(EMG)，该产品主要特点在于可实现高精度信号采集功能，可应用于非侵入式脑机接口领域。该产 品用于人体生物电信号的高精度测量，其适用于各种可穿戴式设备应用场景，技术路线与当前国际上的 侵入式脑机接口存在显著技术路径差异。 截至本公告披露日，该产品在非侵入式脑机接口领域尚处于市场培育期，尚未实现规模化销售，暂未对 公司业绩产生重大影响，未来销售情况存在不确定性。 智通财经APP讯， 英集芯(688209.SH)发布公告，公司于2026年1月6日在上证E互动平台就投资者"脑机 接口"相关问题作出回复，为保障广大投资者的合法权益，公司就相关业务情况补充说明，并进行风险 事项提示如下： ...

一、公司产品具体说明 公司与参股公司精芯唯尔（常州）电子科技有限公司（以下简称"精芯唯尔"） 共同推出的 IPA1299 是一款支持 8 通道低噪声设计，24 位同步采样模数转换器 芯片（ADC），主要应用于脑电图（EEG）、心电图（ECG）和肌电图（EMG）， 该产品主要特点在于可实现高精度信号采集功能，可应用于非侵入式脑机接口领 域。该产品用于人体生物电信号的高精度测量，其适用于各种可穿戴式设备应用 场景，技术路线与当前国际上的侵入式脑机接口存在显著技术路径差异。 证券代码：688209 证券简称：英集芯 公告编号：2026-002 深圳英集芯科技股份有限公司 关于上证 E 互动平台有关问题回复的说明公告 深圳英集芯科技股份有限公司（以下简称"公司"）于 2026 年 1 月 6 日在 上证 E 互动平台就投资者"脑机接口"相关问题作出回复，为保障广大投资者 的合法权益，公司就相关业务情况补充说明，并进行风险事项提示如下，敬请广 大投资者审慎决策，注意投资风险。 截至本公告披露日，该产品在非侵入式脑机接口领域尚处于市场培育期，尚 未实现规模化销售，暂未对公司业绩产生重大影响，未来销售情况存在不确定性。 二 ...